Gain Therapeutics Inc. (GANX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Marshall Wace LLP

Paul Marshall And Ian Wace

1,769,788 $3,433,389 +7% 0%
2.
Potomac Capital Management

Paul Solit And Eric Singer

1,008,600 $1,956,684 -1% 1.7%
3.
Greenlight Capital

David Einhorn

566,130 $1,098,292 0.03%
4.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

35,820 $69,491 0.01%
5. 31,400 $60,916 +21% 0%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$1.01 14,400 $14,544.00 14,400 2024-08-09 Filing
$1.00 50,000 $49,940.00 50,000 2024-08-09 Filing
$1.21 12,000 $14,520.00 289,629 2024-07-01 Filing
$1.23 5,000 $6,150.00 277,629 2024-07-01 Filing
$3.86 30,000 $115,770.00 30,000 2024-03-28 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$2.46 206 $506.76 5,286 2023-12-21 Filing
$2.50 1,820 $4,550.00 4,855 2023-12-07 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 631,615 $1,155,855 0%
2. 447,342 $868,527 0%
3. 431,267 $836,658 0%
4. 399,886 $775,779 0%
5. 229,979 $446,159 0%
News See All